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Apoptosismplicated in regulating a diverse array of cellular functions in the developing
nervous system. Recently, Eph receptors have been shown to promote cell death in adult germinal zones;
however, their mechanisms of action remain ill-deﬁned. In this study, we demonstrate that EphA4 is a new
member of the dependence receptors family, which can initiate cell death in the absence of its ligand
ephrinB3. Upon removal of its ligand, EphA4 triggers cell death that is dependent on caspase activation as
caspase inhibitors prevent cell death. EphA4 itself is cleaved by caspase-3-like caspase in the intracellular
domain at position D773/774, which is necessary for cell death initiation as mutation of the cleavage site
abolishes apoptosis. In the adult subventricular zone, abolishing ephrinB3 results in increased cell death,
while the absence of EphA4 results in excessive numbers of neuroblasts. Furthermore, infusion of soluble
ephrinB3 into the lateral ventricle reduced cell death, and together these results support a dependence role
for EphA4 in adult neurogenesis.
© 2008 Elsevier B.V. All rights reserved.1. IntroductionEph receptors constitute the largest family of receptor tyrosine
kinases inmammalians and are subdivided into twoA andB classes, and
bindeither A-class or B-class ligands. Receptor–ligand interactions occur
upon cell–cell contact as both receptors and ligands are membrane-
bound, and control various mechanisms such as axon pathﬁnding and
branching, dendritic spine modeling, angiogenesis, cell migration and
positioning [1]. Recently, they were shown to be expressed in the
subventricular zone (SVZ), and control stem/progenitor cells prolifera-
tion and fate [2–5]. More surprisingly, some ephrins and Eph receptors
were found to affect cell death in neurogenic regions. Stimulation of
EphA7 through ectopic over-expression of ephrinA5 in the embryonic
cortex induced a wave of neural progenitor apoptosis, thus inﬂuencing
the development of the brain [6]. In contrast, we observed that the
absence of ephrinB3 was associated with an increase in TUNEL-positive
cells in the SVZ of adult mice [4]. The fact that the lack of ephrinB3 may
increase cell death led us to question whether its receptor(s) may
function as a dependence receptor.at Laboratory Apoptosis Cancer
ard, University of Lyon, Lyon,
University of Miami, 1095 NW
USA. Tel.: +1305 243 7143, fax:
are co-corresponding authors.
l rights reserved.Dependence receptors can transduce two different types of signals.
When bound to their ligand, they transduce a positive signal that
elicits a positive response such as survival, differentiation or
migration. However, when deprived of their ligand, they trigger
apoptosis. Dependence receptors include p75NTR, the netrin receptors
DCC and Unc5H1-3, Ret, the androgen receptor, Patched, the αVβ3
integrin, APP [7], as well as Neogenin, Met, and TrkC [8–10].
Dependence receptors are cleaved by speciﬁc caspases, leading to
the release/exposure of an addiction/dependence domain (ADD),
which can amplify caspase activity [11]. Mutation of the caspase
cleavage site abolishes the pro-apoptotic activity of the receptors.
Furthermore, computational analyses unveiled a conserved motif in
the transmembrane region of the known dependence receptors
named the DART (Dependence-Associated Receptor Transmembrane)
motif [12]. Here we show that EphA4 is a new dependence receptor,
where it induces apoptotic cell death, is cleaved by caspase, and that
its pro-apoptotic effect can be blocked by ephrinB3. In the adult
germinal zone, ephrinB3 and EphA4 function to regulate cell numbers,
where EphA4 functions as a dependence receptor in the absence of
ephrinB3.
2. Materials and methods
2.1. Plasmids
EphA4 was subcloned into pcDNA 3.1 His-V5 (InVitrogen). EphA4
intracellular domain was subcloned into pcDNA3.1 (InVitrogen) by
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tcagacaggaaccatcctgc-3′. The construct for the kinase dead mutant
pcDNA3-EphA4-K653M was obtained from Dr Joachim Egea (Mar-
tinsried, Germany). EphA4 mutants were obtained by Quick change
site directed mutagenesis (Stratagene) using the following primers:
EphA4-D773/774N: ggtgctggagaataaccccgaagc and gcttcggggttattctc-
cagcacc; EphA4-D806N: ctcagccagtaatgtctggag and ctccagacat-
tactggctgag; EphA4-Y596/602F: agttctaacaccttgattcaaatgtttctc and
caaggtgttagaacttttgtggatccc, tgtaaagggatccacataagttctaacacc and
gtggatccctttacattcgaagaccccaac.
2.2. Cell culture and death analysis
Cell death was analyzed as described previously [13]. Brieﬂy,
100,000 HEK 293T cells were transfected with 1.5 μg DNA using
Lipofectamine (InVitrogen) for 6 h. The medium was replaced with
DMEM without serum and cell death was analyzed 48 h later using
Trypan blue exclusion. Pre-clustered ephrinB3-Fc (R & D Systems) was
added at the time of medium change and again 24 h later at a ﬁnal
concentration of 1 μg/ml. Clustering was performed with goat anti-
human Fc antibodies (1:10 anti-Fc:ligand) for 1 h at 37 °C. Apoptosis
was quantiﬁed by TUNEL assay (In Situ Cell Death kit, Roche) following
the manufacturer's instructions. Apoptosis was also analyzed using
the caspase substrate caspACE FITC-VAD-fmk (Promega). Brieﬂy, 48 h
after transfection, the cells were washed and resuspended in PBS and
incubated 20 min at 37 °C with 10 μM caspACE-FITC-VAD-fmkFig. 1. EphA4 enhances apoptotic cell death that is blocked in a dose-dependent manner by e
dead cells as measured by Trypan blue exclusion. Addition of pre-clustered soluble ephrinB3
over-expression leads to an increase in TUNEL-positive cells 48 h after transfection. The num
(c) Representative pictures of TUNEL staining (quantiﬁcation shown in (b)). The TUNEL-posi
induce cell death in a dose-dependent manner. The experiments were performed at least th
representative experiment shown). ⁎pb0.05; ⁎⁎pb0.01; ⁎⁎⁎pb0.001.(Promega). They were counted using a FACS Calibur (Becton
Dickinson) and cellQuest analysis software (excitation and emission:
488 nm and 525–550 nm). Apoptosis was also quantiﬁed with the
Caspase-3 Fluorometric Assay Kit (Gentaur). Caspase inhibitors z-
VAD-fmk and z-DEVD-fmk were used at 10 μM.
2.3. Caspase cleavage reactions
Puriﬁed caspases were a generous gift from Guy Salvesen (The
Burnham Institute, La Jolla, CA). The intracellular domain of EphA4
(amino acids 571–987) was cloned into pcDNA3.1 (InVitrogen) and
was transcribed and translated in vitro using the TNT system
(Promega). To analyze receptor cleavage in 293T cells, cells were
washed once in PBS and lysed in 20mMHepes–KOH,10mMKCl, 1.5 M
MgCl2, 1 mM sodium EDTA, 1 mM sodium EGTA, 0.1 mM PMSF buffer
containing DTT, pepstatin, leupeptin and aprotinin. The lysates were
then incubated for 30min at 37 °C. Immunoblotswere then performed
using an anti-V5 antibody (InVitrogen). In vitro transcription/transla-
tion and incubation with caspase 3 or 8 were performed as described
previously [13].
2.4. Protein analysis
Expressed proteins were immunoprecipitated with an anti-V5
(Invitrogen) or anti-EphA4 antibody (Santa Cruz) (in the case of
EphA4-K653M) using a ratio of 1 μg Ab/100 μg protein extractphrinB3. (a) HEK 293T cell cultures over-expressing EphA4 showed a higher number of
in the mediumwas able to reduce the amount of cells stained by Trypan blue. (b) EphA4
ber of TUNEL-positive cells is reduced upon addition of soluble ephrinB3 in the medium.
tive cells appear dark (a few are seen in the middle panel). (d) EphrinB3 blocked EphA4
ree times and the bars on the graphs represent the means of three separate wells (one
Fig. 2. EphA4 induces caspase activation. (a) Caspase activity was increased as a result of
EphA4 over-expression. This increase in caspase activity was reduced by adding
ephrinB3 to the cell medium or by incubating the cells with the caspase inhibitor z-
VAD-fmk or caspase-3 inhibitor zDEVD-fmk. Staurosporinwas used as a positive control
to induce apoptosis. The experiment was performed at least three times and the bars on
the graphs represent the means of three separate wells (one representative experiment
shown). (b) EphA4 cleavage fragments were observed 48 h after over-expression. These
small fragments (19–23 kDa) are no longer present upon addition of the caspase
inhibitor z-VAD-fmk, supporting caspase cleavage of EphA4. ⁎⁎pb0.01.
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added for 30 min. Washes were performed in 10 mM Tris–HCl, pH 7.0,
1 mM EDTA, 0.5% Triton X-100 with decreasing salt concentrations
(1 M NaCl, then 0.2 M NaCl, then no NaCl). Immunoprecipitates were
boiled and run on SDS-PAGE gels, transferred and the membranes
were probed with either anti-V5 or anti-EphA4 antibodies, and anti-
phosphotyrosine antibodies (BD Pharmingen).
2.5. Animals and tissue analysis
Two-month old male CD1mice were used following the University
of Miami Institutional Animal Care and Use Committee guidelines.
Animals were perfused intracardially with 4% paraformaldehyde and
the brains were harvested, frozen in OCT (Tissue-Tek) and sectioned
using a cryostat. Anti-PSA-NCAM (Chemicon) was used at 1:1000 for
1 h at room temperature. Labeling of proliferating cells was performed
by injecting BrdU (50 μg/g body weight) intraperitoneally for 1 h. Mice
were perfused with paraformaldehyde and cryostat sections were
stained with anti-BrdU antibodies after treatment of the tissue with
2 N HCl for 30 min at 37 °C followed by neutralization with 0.1 M
sodium borate pH 8.5. Pre-clustered ephrinB3-Fc (140 μg/ml in PBS)
and z-VAD-fmk (50 μM) were infused into the lateral ventricle at the
following coordinates from bregma (P: −0.5 mm; L: 0.7 mm; 3 mm
below dura) using Alzet osmotic pumps (model 1007D) connected to a
brain infusion device placed on the skull. Animals were perfused after
7 days of infusion. TUNEL staining was performed using the ApopTag
kit (Chemicon) following the manufacturer's instructions. Stereologi-
cal counts were performed using the StereoInvestigator software
(MicroBrightﬁeld) on 16 μm sections every ﬁfteenth section.
3. Results
3.1. EphA4 functions as a pro-apoptotic receptor in the absence of
ephrinB3
EphA4was transiently over-expressed in human embryonic kidney
(HEK) 293T cells, and cell death was monitored 2 days after
transfection using trypan blue exclusion. Over-expression of EphA4
was able to increase the level of dead cells as compared to cells
transfectedwith amock vector (Fig.1a, b; Suppl. Fig.1). A similar effect
was observed in NIH3T3 ﬁbroblasts and immortalized neuronal 13.
S.24 cells (not shown). The enhancement of cell death induced by
EphA4 could be reversed by adding its ligand ephrinB3 (Fig. 1a–c) in a
dose-dependent manner (Fig. 1d), whereas little to no effects were
observed with soluble ephrinA1 or ephrinA4 (Suppl. Fig. 2) or in
control 293T cells treated with ephrinB3 (not shown). EphA4-induced
cell death was concluded to be apoptotic for two reasons: (i) EphA4
expression induced an increase in DNA degradation as visualized by
TUNEL staining (Fig. 1c, d) and (ii) it triggered caspase activity as
determined bymeasuring the cleavage of the FITC-VAD-fmk substrate
(Fig. 2a). Our observations suggest that EphA4 functions as a
dependence receptor as it induces apoptosis when dissociated from
its ligand.
3.2. Pro-apoptotic functions of EphA4 require caspase cleavage
To further elucidate the molecular mechanisms of EphA4-induced
cell death, we studied the involvement of caspases. Treatment with
the broad range caspase inhibitor z-VAD-fmk and the caspase-3
inhibitor zDEVD-fmk blocked EphA4-induced cell death (Fig. 2a),
supporting a caspase-dependent mechanism. Dependence receptors
have been shown to require a preliminary caspase cleavage of their
intracellular domain to trigger cell death [11]. As shown in Fig. 2b,
Western blot analysis following full-length EphA4 expression in
HEK293Tcells revealed lowermigrating bands at 19–23 kDa as a result
of EphA4 cleavage that is inhibited by zVAD-fmk.To further establish a direct cleavage of the EphA4 intracellular
domain by caspases, the last 446 C-terminal amino acids were
transcribed and translated in vitro. The product was incubated with
puriﬁed active caspase-3 or caspase-8. Fig. 3a shows that the
intracellular domain of EphA4 was cleaved by caspase-3 but not by
caspase-8, and this resulted in cleavage product(s) migrating at
approximately 19–23 kDa. This demonstrated that EphA4 is a
substrate for caspase-3-like caspases, and that it has at least one
caspase cleavage site in its intracellular domain as shown for the vast
majority of dependence receptors [7]. Since caspases cleavage sites
have been shown to contain an aspartic acid residue in the P1 position
[14], we generated DNN mutants in the EphA4 region encompassing
the last 250 amino acids to match the size of the cleavage fragment.
The mutation of residues D773/774N prevented cleavage by caspase-3
in vitro (Fig. 3b).
The overall dependence receptor notion hypothesizes that the
caspase cleavage of the intracellular domain of dependence receptors
is inhibited in the presence of their ligand [13,15]. We then analyzed
whether EphA4 cleavage could also be blocked by application of
ephrinB3. As shown in Fig. 3c, application of ephrinB3 strongly
inhibited the apparition of the 19–23 kDa, which was similar to
inhibition by zVAD-fmk and the D773/774 mutation.
Fig. 3. EphA4 is a substrate for caspase-3 like caspase. (a) The intracellular fragment of EphA4 (aa 571–987) was expressed in vitro and incubated with caspases. Caspase-3, but not
caspase-8, triggered the release of smaller fragments (19–23 kDa). The other bands present on the blots most likely reﬂect non-speciﬁc translation initiated at different methionine
residues, as shown and described previously [13]. (b) Mutants DNN were generated to locate the caspase cleavage site. Mutation of residues D773/774 prevented the release of the
small 19–23 kDa fragments, where lower molecular weight bands were resolved using a gradient gel. The mutant D806N is shown as a control to illustrate the speciﬁcity of cleavage.
(c) EphrinB3 could block EphA4 cleavage similar to application of zVAD-fmk and the D773/774N mutant EphA4 receptor. (d) The mutant EphA4 D773/774N does not induce
signiﬁcantly greater cell death than the control. (e) The mutant EphA4 D773/774N does not induce greater caspase activation than the control. The levels of caspase activation are
similar to the ones observed in the presence of ephrinB3. (f) The pro-apoptotic domain of EphA4 is located upstream from the cleavage site. The two fragments that would be
generated upon caspase cleavage (aa1–774 and aa775–987) were over-expressed separately, cell death was observed with the amino terminal fragment but not the carboxy terminal
fragment. ⁎pb0.05; ⁎⁎pb0.01.
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the unveiling and release of a pro-apoptotic Addiction/Dependence
Domain (ADD) [7]. We then assessed whether the caspase-cleavage of
EphA4 is required for cell death induction. Forced expression of the
D773/774N mutant form of EphA4 in HEK 293T cells was not able to
trigger cell death (Fig. 3d) or caspase activation (Fig. 3e). We therefore
transfected cells with constructs encoding for the two fragments that
would be generated after caspase cleavage: an N-terminal ‘truncated’protein encompassing amino acids 1–774 and a C-terminal fragment
encompassing amino acids 775–987. Expression of the N-terminal
fragment induced cell death similar to full length EphA4, whereas the
C-terminal fragment showed no signiﬁcant effect (Fig. 3f). This
suggested that the ADD domain is located N-terminal to the D773/
774 caspase cleavage site on the EphA4 protein, and is similar in that
regard to the Neogenin, Patched or DCC dependence receptors
[8,13,15].
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phosphorylation
To further evaluate whether EphA4 activation is critical for
inhibiting its pro-apoptotic effects, we examined the requirement
for EphA4 phosphorylation. Upon stimulationwith its ligand, EphA4 is
known to undergo oligomerization that results in trans-phosphoryla-
tion of receptor dimers, however, it is a well-recognized concept that
over-expression of receptor tyrosine kinases can lead to auto-
phosphorylation. To address whether autophosphorylation can affect
EphA4 pro-apoptotic activity, we evaluated to role of EphA4
phosphorylation using a kinase-dead EphA4 mutant (EphA4 K653M)
and a mutant where two juxtamembrane tyrosines are mutated to
phenylalanine (EphA4 Y596/602F). The juxtamembrane tyrosine
residues are highly conserved among receptor tyrosine kinases, and
have been shown to control auto-inhibition of receptor tyrosine
kinases in general [16] and Eph receptors [17,18]. To conﬁrm the anti-
phosphorylation potential of the two mutant receptors, we trans-
fected HEK 293Tcells with wild type EphA4 (V5-tagged), EphA4 Y596/
602F (V5-tagged), or EphA4 K653M (untagged) receptors (Fig. 4a).
Immunoprecipitation (IP) blots demonstrated that all three receptorsFig. 4. The kinase activity of EphA4 is not necessary for cell death induction. Two mutants w
two mutated juxtamembrane tyrosine residues (Y596/602F) that prevent full intracell
phosphorylation of the receptor, whereas the twomutants do not show tyrosine phosphoryla
able to induce cell death like the wild type form when over-expressed. (c) The D773/774N
Phosphorylation of EphA4 D773/774N is increased after ephrinB3 addition. Lanes 1, 2: pcDNA
with ephrinB3. ⁎pb0.05; ⁎⁎pb0.01.were expressed in HEK 293Tcells following transient-transfection, but
only wild type EphA4 was phosphorylated. Cell death assays
demonstrated that the two mutant EphA4 receptors retained their
ability to induce cell death as compared to wild type EphA4 (Fig. 4b),
and application of ephrinB3 could inhibit EphA4-induced cell death in
both the wild type and kinase-dead mutant (Suppl. Fig. 3).
Furthermore, analysis of the D773/774 mutant EphA4 receptor
showed similar phosphorylation levels to wild type EphA4 (Fig. 4c),
suggesting that EphA4 phosphorylation and activation are not
implicated in the pro-apoptotic activity of EphA4. Moreover, the lack
of cell death induction by the D773/774N mutant is not due to an
impairment of activation, which may occur because of the location of
the mutation in the activation loop, as EphA4 retained the ability to be
phosphorylated by ephrinB3 (Fig. 4d).
3.4. EphA4 functions as a dependence receptor for neural progenitor cells
that reside in the adult SVZ
Previously we had observed an increase in TUNEL-positive cells in
the germinal zone of ephrinB3−/−mice [4], suggesting that EphA4may
function to induce cell death in the absence of ephrinB3. To test thisere compared to the wild type form: a kinase dead mutant (K653M) and a mutant with
ular domain activation. (a) Over-expression of EphA4 in HEK 293T cells leads to
tion. (b) Despite their lack of tyrosine phosphorylation, the two EphA4 mutants are still
mutant EphA4 receptor could be phosphorylated when incubated with ephrinB3. (d)
3; lanes 3, 4: EphA4-V5; lanes 5, 6: EphA4 D773/774N-V5. Lanes 2, 4 and 6: stimulation
Fig. 5. EphA4−/− animals have an enlarged SVZ and RMS. (a) EphA4 is expressed in the SVZ tissue and SVZ progenitor cells grown as neurospheres in vitro. (b) EphA4 protein is
expressed in progenitor cells grown as neurospheres, but is absent in neurospheres derived from EphA4−/− mice. The EphA4−/− mice show an accumulation of PSA-NCAM-positive
(red) neuroblasts (d) as compared towild type littermates (c) The green staining corresponds to GFAP. The RMS of EphA4−/− animals is also enlarged and contains more neuroblasts (f)
compared to wild type littermates (e). (g) Proliferation in the SVZ of EphA4−/−, analyzed by BrdU incorporation or Ki67 staining, was found to be unaffected in the EphA4−/− mice. (h)
EphA4−/− mice have a similar number of dying cells in the SVZ (labeled by TUNEL), whereas ephrinB3−/− show a signiﬁcant increase in cell death in the SVZ. However, compared to
the total cell population or the neuroblasts population of the SVZ, less dying cells are present in the EphA4−/− SVZ. (j) Infusion of soluble ephrinB3-Fc into the lateral ventricle of
ephrinB3−/− and wild type mice reduces the amount of TUNEL-positive cells, showing that it can act as an anti-apoptotic factor in vivo.
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absence of EphA4. Neural progenitor cells were isolated from SVZ
tissues and grown as neurospheres. Tissue extracts and puriﬁed
neurospheres were found to express EphA4 mRNA (Fig. 5a) andprotein (Fig. 5b). Immunohistological examination of the SVZ area
revealed a striking phenotype around the lateral ventricles, where
excessive numbers of PSA-NCAM-positive neuroblasts accumulated in
the SVZ and rostral migratory stream (RMS) of EphA4−/− mice as
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whether the increased numbers of neuroblasts resulted from
increased proliferation and/or decreased cell death, we quantiﬁed
the numbers of BrdU- and Ki67-labeled cells (markers for prolifera-
tion) and TUNEL-labeled cells (marker of cell death) in the SVZ using
non-biased stereological measurements. Quantiﬁcation of Ki67 stain-
ing or BrdU incorporation demonstrated that the observed increase in
neuroblasts numbers did not result from increased proliferation (Fig.
5g). Our initial examination of TUNEL-positive cells revealed a
signiﬁcant increase in the ephrinB3−/− mice, while EphA4−/− mice
had similar levels to Wt controls (Fig. 5h). Although, when TUNEL-
positive cells were standardized against the difference in total cell
numbers between Wt and EphA4−/− mice, there was a signiﬁcant
reduction in the percentage of TUNEL-positive cells associated with
the absence of EphA4 (Fig. 5i). This would suggest that the increase in
neuroblasts in EphA4−/− mice may reﬂect, in part, a reduction in cell
death in the adult SVZ. To provide additional gain-of-function support,
we infused ephrinB3 back into the SVZ of both Wt and ephrinB3−/−
mice in an attempt to reduce cell death. Fig. 5j shows that animals
receiving soluble ephrinB3 for 1 week had a reduction in the
percentage of TUNEL-positive cells in both ephrinB3−/− and Wt mice.
These ﬁndings support the dependence receptor role for EphA4 in
cells that reside in the adult SVZ, and the ability of ephrinB3 to
regulate neurogenesis.
4. Discussion
In the present article, we demonstrate that EphA4 shares
characteristics similar to the ones observed for a new group of
proteins called dependence receptors. EphA4 is able to trigger
caspase-dependent cell death, which can be speciﬁcally blocked by
its ligand ephrinB3. EphA4 is itself a substrate of a caspase-3-like
caspase and its cleavage at amino acid position D773/774 is necessary
for the induction of cell death. One potential role for EphA4 as a
dependence receptor is to regulate neurogenesis in the adult SVZ,
where the absence of its ligand ephrinB3 leads to increased cell death
and the absence of EphA4 leads to excessive numbers of neuroblasts.
Recent studies have implicated Eph receptors in regulating cell
death. EphA7 was shown to initiate cell death in neuronal progenitors
when activated by ephrinA5 in the embryo [6]. This pro-apoptotic
effect of ephrinA5 contradicts our dependence receptor mechanism
cell death, where ephrinB3 is anti-apoptotic, suggesting that all Eph
receptors do not function as dependence receptors. Recently, the DART
motif has been identiﬁed in the trans-membrane region of depen-
dence receptors [12]. This motif is present on EphA4 but not all Eph
receptors (G. del Rio, personal communication). The function of the
DART motif is unknown but could regulate homomultimerization of
dependence receptors. Indeed it is thought that oligomerization
caused by ligand binding may prevent monomer-induced cell death,
as was shown for the p75 receptor [11,19]. This hypothesis is
reinforced by our ﬁnding that mutant forms of EphA4 that are unable
to trans-phosphorylate are still able to initiate cell death, suggesting
that the activation of the receptor is not critical for induction of cell
death. TrkC kinase activity was also found to be dispensable in
triggering apoptosis [9].
For most dependence receptors, the mechanism(s) of caspase
binding, signal transduction, and caspase activation remain ill-
deﬁned. However, for many dependence receptors caspase cleavage
leads to the release of a pro-apoptotic addiction/dependence domain
(ADD). Our studies demonstrate that following caspase cleavage the C-
terminus fragment is inactive, whereas the remaining N-terminus
‘truncated’ EphA4 receptor initiates the apoptotic cascade. This
suggests that the ADD domain is upstream of the D773/774 cleavage
site, which is similar to the dependence receptor Neogenin [8].
Although, the possibility exists that there is another cleavage site
upstream of D773/774 that releases a second fragment and containsthe ADD domain. However, it is clear that D773/774 cleavage is
required for induction of EphA4-mediated cell death. This non-
canonical cleavage site is located within the activation loop of the
kinase domain, although the mutant protein exhibits tyrosine
phosphorylation in both non-stimulated and ephrinB3 stimulated
conditions. This demonstrates that the D773/774 mutant retains the
ability to be phosphorylated, however, analysis of the kinase-dead
mutants strongly support a kinase-independent role of EphA4 in the
apoptotic process through the elimination of the caspase cleavage site.
The dependence receptors DCC, Ret, Met and TrkC all contain two
cleavage sites [7,9]. Another intriguing observation is that not all
ligands are able to block the pro-apoptotic function of EphA4. Unlike
ephrinB3, the A-class ligands ephrinA1 and ephrinA4, which bind
EphA4 with good afﬁnity in vitro, were not able to inhibit cell death. It
is unclear why ephrinB3 and not ephrinA1 or A4 can inhibit EphA4-
mediated cell death, however, minor differences in structure and
binding may play a role to regulate caspase-3 cleavage. Furthermore,
while in vitro binding assays have shown strong binding afﬁnities
between EphA4 and the three ephrins, less is know about physiolo-
gical interactions. What is known is that there is strong biological
relevance of ephrinB3-EphA4 interactions, where many abnormalities
associated with the ephrinB3−/− mice phenocopy the EphA4−/− mice.
Dependence receptors are now recognized as potential tumor
suppressors [7], and both DCC and Unc5H are considered tumor
suppressors in colorectal malignancies [20]. Recently, over-expression
of EphA2 has been shown to trigger apoptosis in cancer cell lines [21],
supporting the dependence receptor role of Eph receptors. In addition,
EphA4 is down-regulated in invasive forms of breast cancer [22] and in
liver and kidneycancer [23]. EphA4was also lost inmetastaticmelanoma
[24], and this ﬁnding is in agreement with the hypothesis that malignant
metastatic tumors may thrive in the absence of pro-apoptotic depen-
dence receptors [25]. Reductions in EphB2, EphB3 or EphB4 expression
correlate with tumor progression and malignancy in colorectal cancers
[26–29], while EphB over-expression reduces cell growth in certain
cancer cell lines [28–30]. Like EphA4, EphB3 also contains theDARTmotif
and may be a putative new dependence receptor [12]. Finally, the pro-
apoptotic role of Eph receptors is also supported by ephrin siRNA
knockdown studies where cell growth is retarded [31].
The identiﬁcation of EphA4 as a pro-apoptotic dependence
receptor in the adult SVZ is an intriguing mechanism for the
regulation of neural progenitor cell numbers. This suggests that
EphA4-expressing NPCs require at least intermittent interactions with
ephrins to survive. EphrinB3 is localized to regions surrounding the
SVZ and RMS, but not within these neurogenic regions [4]. In the
absence of EphA4, we observe a large increase of the neuroblast
population in both the SVZ and the RMS. This phenotype has also been
observed in mice lacking the pro-apoptotic genes Bax and Bak [32–
34]. It is noteworthy that like the EphA4−/− mice, the Bax−/− and Bak−/−
mice did not exhibit any change in cell proliferation. We cannot
exclude the possibility that defects in cell migration may also play a
role in the build up of neuroblasts in the EphA4−/− mice. Impaired
migration has been found in the Bax−/− mice [32], but it is difﬁcult to
separate defects in migration from apoptosis when defects in
programmed cell death can lead to increased cell numbers that may
indirectly alter migratory potential (i.e. bottleneck phenomenon). For
these reasons, additional studies are required to address migratory
defects in EphA4−/− mice.
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